|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-3-31
|
|
pubmed:abstractText |
We report the local control and survival of two Phase I dose escalation trials of combined preoperative 5-fluorouracil (5-FU), low-dose leucovorin (LV), and radiation therapy followed by postoperative LV/5-FU for the treatment of patients with locally advanced and unresectable rectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
pubmed-author:BaslMM,
pubmed-author:CohenA MAM,
pubmed-author:ConteNN,
pubmed-author:EnkerW EWE,
pubmed-author:GuillemJ GJG,
pubmed-author:IlsonDD,
pubmed-author:KelsenD PDP,
pubmed-author:KemenyNN,
pubmed-author:MinskyB DBD,
pubmed-author:PengG CGC,
pubmed-author:SaltzLL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
289-95
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9069299-Adult,
pubmed-meshheading:9069299-Aged,
pubmed-meshheading:9069299-Antidotes,
pubmed-meshheading:9069299-Antimetabolites, Antineoplastic,
pubmed-meshheading:9069299-Combined Modality Therapy,
pubmed-meshheading:9069299-Disease-Free Survival,
pubmed-meshheading:9069299-Female,
pubmed-meshheading:9069299-Fluorouracil,
pubmed-meshheading:9069299-Humans,
pubmed-meshheading:9069299-Leucovorin,
pubmed-meshheading:9069299-Male,
pubmed-meshheading:9069299-Middle Aged,
pubmed-meshheading:9069299-Rectal Neoplasms
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
